Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
2012 · Nature · 1,103 citations
https://doi.org/10.1038/nature11249
E
Elicia Penuel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
216
Papers
5.2K
Citations
29
h-index
54
i10-index
Elicia Penuel is an academic researcher. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Lymphoma Diagnosis and Treatment & HER2/EGFR in Cancer Research. The author has an h-index of 29, co-authored 184 publications.
ORCID: 0000-0001-7285-1929Papers by this author
worksTrastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers
2011 · Cancer Research · 223 citations
https://doi.org/10.1158/0008-5472.can-10-1872
Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients
2010 · Clinical Cancer Research · 161 citations
https://doi.org/10.1158/1078-0432.ccr-10-0410
A Novel Proximity Assay for the Detection of Proteins and Protein Complexes: Quantitation of HER1 and HER2 Total Protein Expression and Homodimerization in Formalin-fixed, Paraffin-Embedded Cell Lines and Breast Cancer Tissue
2009 · Diagnostic Molecular Pathology · 89 citations
https://doi.org/10.1097/pdm.0b013e31818cbdb2
Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter
2016 · Oncogene · 84 citations
https://doi.org/10.1038/onc.2016.170
EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance
2009 · Breast Cancer Research and Treatment · 79 citations
https://doi.org/10.1007/s10549-009-0592-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat